Safety and Immunogenicity of a Locally Produced Inactivated NDV-HXP-S COVID-19 Vaccine (HXP-GPOVac) Compared with BNT162b2: A Phase II Randomized, Controlled, Double-Blind Noninferiority Trial in Thai Adults. - Prasert K; Nakphook S; Kittiwatanachod J; Sornwong K; Naosri S; Ongarj P; Techatanawat I; Narakorn P; Surichan S; Flores J; Mercer LD; Polyak CS; et al. (Vaccines, 2026)